These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3624077)
21. Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids. Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K J Antibiot (Tokyo); 1993 Feb; 46(2):316-30. PubMed ID: 8468248 [TBL] [Abstract][Full Text] [Related]
22. Aminothiazolylglycyl derivatives of carbacephems. I. Synthesis and antibacterial activity of novel carbacephems with substituted aminothiazolyl groups. Mochida K; Shiraki C; Yamasaki M; Hirata T; Sato K; Okachi R J Antibiot (Tokyo); 1987 Jan; 40(1):14-21. PubMed ID: 3558115 [TBL] [Abstract][Full Text] [Related]
23. New broad-spectrum cephalosporins with anti-pseudomonal activity. I. Synthesis and antibacterial activity of 7 beta-[D-2-[(4-hydroxy-1,5-naphthyridine-3-carbonylamino)- and (4-hydroxypyridine-3-carbonylamino)]-2-(4-hydoxyphenyl)acetamido] cephalosporins. Yamada H; Jimpo K; Tobiki H; Komatsu T; Noguchi H; Irie K; Nakagome T J Antibiot (Tokyo); 1983 May; 36(5):522-31. PubMed ID: 6409868 [TBL] [Abstract][Full Text] [Related]
24. Studies on beta-lactam antibiotics. XIX. Structure-activity relationships of cephalosporins having a thiadiazolylthiomethyl group at the C-3 side chain. Inamoto Y; Goto J; Sakane K; Kamimura T; Takaya T J Antibiot (Tokyo); 1991 May; 44(5):507-16. PubMed ID: 2061194 [TBL] [Abstract][Full Text] [Related]
25. A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships. Numata M; Minamida I; Yamaoka M; Shiraishi M; Miyawaki T; Akimoto H; Naito K; Kida M J Antibiot (Tokyo); 1978 Dec; 31(12):1262-71. PubMed ID: 367998 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro activity of new cephalosporin derivatives containing a benzoxazolone ring. Kalcheva V; Mincheva Z; Andreeva P Arzneimittelforschung; 1990 Sep; 40(9):1030-4. PubMed ID: 2080938 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of a series of new parenteral optically active 3-[[(N-alkylpyridinium-4'-yl)thio]methyl]-2-oxaisocephems. Tsubouchi H; Tsuji K; Yasumura K; Matsumoto M; Shitsuta T; Ishikawa H J Med Chem; 1995 Jun; 38(12):2152-7. PubMed ID: 7783146 [TBL] [Abstract][Full Text] [Related]
28. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships. Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419 [TBL] [Abstract][Full Text] [Related]
29. An examination of O-2-isocephems as orally absorbable antibiotics. Mastalerz H; Menard M; Vinet V; Desiderio J; Fung-Tomc J; Kessler R; Tsai Y J Med Chem; 1988 Jun; 31(6):1190-6. PubMed ID: 3373488 [TBL] [Abstract][Full Text] [Related]
30. A novel series of parenteral cephalosporins exhibiting potent activities against both Pseudomonas aeruginosa and other gram-negative pathogens. Part 2: Synthesis and structure-activity relationships. Yamawaki K; Nomura T; Yasukata T; Tanimoto N; Uotani K; Miwa H; Yamano Y; Takeda K; Nishitani Y Bioorg Med Chem; 2008 Feb; 16(4):1632-47. PubMed ID: 18065229 [TBL] [Abstract][Full Text] [Related]
31. Cephalosporins. III. Synthesis and structure-activity relationships of 7-vinylenethioacetamid:o cephalosporins with a tetrazolo-pyridazine at the 3-position. Nannini G; Perrone E; Severino D; Casabuona F; Bedeschi A; Buzzetti F; Giraldi PN; Meinardi G; Monti G; Ceriani A; de Carneri I J Antibiot (Tokyo); 1981 Nov; 34(11):1456-68. PubMed ID: 7319908 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and activity of potent 3-(isoxazolidin-5-yl)- and 3-(isoxazolidinium-5-yl)cephalosporins. Huang SP; Koyama Y; Ikeda D; Kondo S; Takeuchi T J Antibiot (Tokyo); 1992 Dec; 45(12):1939-48. PubMed ID: 1490887 [TBL] [Abstract][Full Text] [Related]
33. Cephalosporins IV. Synthesis and structure-activity relationships of new 7 alpha-methoxy-7 beta-vinylenethioacetamido cephalosporins. Perrone E; Nannini G; Giudici F; Severino D; Giraldi PN; Meinardi G; Ceriani A J Antibiot (Tokyo); 1982 Mar; 35(3):321-8. PubMed ID: 7076579 [TBL] [Abstract][Full Text] [Related]
34. [Orally active cephalosporins. I. Synthesis and structure-activity relationships of 7 beta-[2-(R)-amino-2-phenylacetamido]-3-(1H- 1,2,3-triazol-4-yl)alkylthiomethyl-3-cephem-4-carboxylic acid and related compounds]. Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K Yakugaku Zasshi; 1992 Sep; 112(9):622-37. PubMed ID: 1469610 [TBL] [Abstract][Full Text] [Related]
36. Studies on semi-synthetic 7 alpha-formamidocephalosporins. III. Synthesis and antibacterial activity of some 7 beta-[D-2-(aryl)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl amino] acetamido]-7 alpha-formamidoceph-3-em-4-carboxylate derivatives. Branch CL; Basker MJ; Finch SC; Guest AW; Harrington FP; Kaura AC; Knott SJ; Milner PH; Pearson MJ J Antibiot (Tokyo); 1987 May; 40(5):646-51. PubMed ID: 3610823 [TBL] [Abstract][Full Text] [Related]
37. Cephalosporins. VI. Synthesis and structure-activity relationships of new 7 beta-[(Z)-2-alkoxyimino-2-(2-aminothiazol-4-yl)acetamido]cephalosporins with a tetraxolopyridazine at the 3-position. Alpegiani M; Casabuona F; Giorgi R; Nannini G; Perrone E; Meinardi G; Bianchi A; Monti G J Antibiot (Tokyo); 1983 Aug; 36(8):1013-9. PubMed ID: 6630053 [TBL] [Abstract][Full Text] [Related]
39. Studies on cephalosporin antibiotics. I. Synthesis, antibacterial activity and oral absorption of new 3-(O-substituted)-7 beta-[D-alpha-amino-alpha-(4-hydroxyphenyl)acetamido]cephalosporins. Yokoo C; Goi M; Onodera A; Murata M; Nagate T; Watanabe Y; Sota K J Antibiot (Tokyo); 1988 Feb; 41(2):170-80. PubMed ID: 3356605 [TBL] [Abstract][Full Text] [Related]